Roche Holding AG (OTC: RHHBY)
Key Data Points
Roche Holding AG Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Roche Holding AG Company Info
Roche Holding AG is a research healthcare company. It operates through the Pharmaceuticals and Diagnostics segments. The Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
News & Analysis
Why Roche Holdings Stock Withered on Wednesday
The company had a dispiriting update to offer about an investigational drug.
Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years
Should Novo Nordisk and Eli Lilly investors be worried about Roche?
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
There are a number of pharmaceutical companies looking to make waves in the weight loss market.
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
Roche's latest breakthrough could be a game changer, but it's still too early to say.
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
Roche might give Lilly and Novo Nordisk a run for their money -- sometime down the road.
This Big Pharma Could Become a Leading Weight-Loss Stock. Should You Buy It?
This company hasn't made its debut on the weight-loss market yet, but it may.
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
Roche has a new GLP-1 weight loss drug in the works -- and one very cheap stock.
Why Roche Holdings Stock Popped Today
Roche's new Alzheimer's test has a long road ahead of it, but it may help boost the pharmaceutical company's slow growth rate.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.